BRPI0911847A2 - composições de pastilhas de nicotina - Google Patents

composições de pastilhas de nicotina

Info

Publication number
BRPI0911847A2
BRPI0911847A2 BRPI0911847A BRPI0911847A BRPI0911847A2 BR PI0911847 A2 BRPI0911847 A2 BR PI0911847A2 BR PI0911847 A BRPI0911847 A BR PI0911847A BR PI0911847 A BRPI0911847 A BR PI0911847A BR PI0911847 A2 BRPI0911847 A2 BR PI0911847A2
Authority
BR
Brazil
Prior art keywords
tablet compositions
nicotine tablet
nicotine
compositions
tablet
Prior art date
Application number
BRPI0911847A
Other languages
English (en)
Inventor
Li-Lan Chen
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41255405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0911847(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of BRPI0911847A2 publication Critical patent/BRPI0911847A2/pt
Publication of BRPI0911847A8 publication Critical patent/BRPI0911847A8/pt
Publication of BRPI0911847B1 publication Critical patent/BRPI0911847B1/pt
Publication of BRPI0911847B8 publication Critical patent/BRPI0911847B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture Of Tobacco Products (AREA)
BRPI0911847A 2008-05-01 2009-04-30 composições de pastilha de nicotina BRPI0911847B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4951508P 2008-05-01 2008-05-01
US61/049.515 2008-05-01
PCT/US2009/042190 WO2009134947A1 (en) 2008-05-01 2009-04-30 Nicotine lozenge compositions

Publications (4)

Publication Number Publication Date
BRPI0911847A2 true BRPI0911847A2 (pt) 2015-10-06
BRPI0911847A8 BRPI0911847A8 (pt) 2018-03-06
BRPI0911847B1 BRPI0911847B1 (pt) 2021-04-13
BRPI0911847B8 BRPI0911847B8 (pt) 2021-05-25

Family

ID=41255405

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911847A BRPI0911847B8 (pt) 2008-05-01 2009-04-30 composições de pastilha de nicotina

Country Status (19)

Country Link
US (3) US8501164B2 (pt)
EP (1) EP2285411B1 (pt)
JP (2) JP5893405B2 (pt)
CN (1) CN102076362B (pt)
AR (1) AR071420A1 (pt)
AU (1) AU2009243065B2 (pt)
BR (1) BRPI0911847B8 (pt)
CA (1) CA2723011A1 (pt)
CL (1) CL2009001025A1 (pt)
DK (1) DK2285411T3 (pt)
ES (1) ES2605244T3 (pt)
HK (1) HK1153146A1 (pt)
HU (1) HUE031175T2 (pt)
MX (1) MX2010011929A (pt)
MY (1) MY164646A (pt)
PL (1) PL2285411T3 (pt)
PT (1) PT2285411T (pt)
RU (1) RU2458692C2 (pt)
WO (1) WO2009134947A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012020731A2 (pt) 2010-02-18 2016-04-26 Jatin Vasant Thakkar pastilhas gelatinosas suaves com nicotina.
UA112974C2 (uk) 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
TW201507726A (zh) * 2013-05-10 2015-03-01 Glaxosmithkline Llc 菸鹼菱形錠配製物
US9999243B2 (en) * 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
DK3052081T3 (da) * 2013-10-03 2021-01-18 Altria Client Services Llc Pastil
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
DK3445344T3 (da) 2016-04-21 2020-11-23 Fertin Pharma As Nikotinadministrationsprodukt, relaterede anvendelser og orale doseringsformer, samt fremgangsmåder til fremstilling
JP7278281B2 (ja) * 2017-12-08 2023-05-19 フェルティン ファルマ アー／エス ニコチン錠
EP3720497A1 (en) * 2017-12-08 2020-10-14 Fertin Pharma A/S High nicotine concentration
US20210345656A1 (en) * 2017-12-08 2021-11-11 Fertin Pharma A/S High nicotine absorption
AU2018378649B2 (en) * 2017-12-08 2021-06-03 Fertin Pharma A/S Solid oral nicotine formulation
CA3040547C (en) 2019-04-17 2021-12-07 Medcan Pharma A/S Cannabinoid lozenge formulation
US11759419B2 (en) * 2019-10-11 2023-09-19 Fertin Pharma A/S Compressed nicotine lozenge
US11000540B1 (en) * 2019-11-22 2021-05-11 Al Siamon Treatment for reducing adverse events including chemotherapy discomfort and other conditions
US20220387328A1 (en) * 2021-06-04 2022-12-08 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Dosage form for nicotine replacement therapy
WO2023053060A1 (en) * 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral gum composition

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
DK0906089T3 (da) 1996-05-13 2003-12-08 Novartis Consumer Health Sa Mundafgivelsessystem
AU774594B2 (en) 1998-12-18 2004-07-01 Alza Corporation Transparent transdermal nicotine delivery devices
FR2792200B3 (fr) 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
NZ530439A (en) 2001-04-20 2004-11-26 Lavipharm Lab Inc Intraoral delivery of nicotine for smoking cessation
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
EP1455751A1 (en) * 2001-12-20 2004-09-15 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
DE60313216T2 (de) * 2002-12-20 2008-01-03 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
US20040182403A1 (en) 2003-02-28 2004-09-23 Sven-Borje Andersson Container comprising nicotine and the use and manufacture thereof
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
ATE422355T1 (de) 2003-09-08 2009-02-15 Mcneil Ab Nikotinformulierungen und ihre verwendung
US20050123502A1 (en) * 2003-10-07 2005-06-09 Chan Shing Y. Nicotine containing oral compositions
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
EP1998755A2 (en) 2006-03-16 2008-12-10 NicoNovum AB Chewing gum compositions providing rapid release of nicotine
US20070269386A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20080287507A1 (en) 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
US20080286340A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090164008A1 (en) * 2007-12-21 2009-06-25 Xin Hong Lens surface with combined diffractive, toric, and aspheric components
MX2011003984A (es) 2008-10-14 2011-05-10 Mcneil Ab Forma de dosis intraoral de multiples porciones y uso de esta.
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
US8807979B2 (en) 2009-09-24 2014-08-19 Mcneil-Ppc, Inc. Machine for the manufacture of dosage forms utilizing radiofrequency energy

Also Published As

Publication number Publication date
ES2605244T3 (es) 2017-03-13
WO2009134947A1 (en) 2009-11-05
EP2285411A1 (en) 2011-02-23
EP2285411B1 (en) 2016-09-21
US20150105431A1 (en) 2015-04-16
US8501164B2 (en) 2013-08-06
PT2285411T (pt) 2016-11-25
RU2010149050A (ru) 2012-06-10
CL2009001025A1 (es) 2010-09-24
HUE031175T2 (en) 2017-06-28
US20110110880A1 (en) 2011-05-12
JP2011519862A (ja) 2011-07-14
CN102076362A (zh) 2011-05-25
CN102076362B (zh) 2015-01-21
PL2285411T3 (pl) 2017-07-31
CA2723011A1 (en) 2009-11-05
MY164646A (en) 2018-01-30
EP2285411A4 (en) 2011-05-18
JP6159761B2 (ja) 2017-07-05
US8940772B2 (en) 2015-01-27
AU2009243065B2 (en) 2013-05-23
RU2458692C2 (ru) 2012-08-20
HK1153146A1 (zh) 2012-03-23
BRPI0911847B1 (pt) 2021-04-13
BRPI0911847A8 (pt) 2018-03-06
JP5893405B2 (ja) 2016-03-23
AR071420A1 (es) 2010-06-16
AU2009243065A1 (en) 2009-11-05
US20130289079A1 (en) 2013-10-31
BRPI0911847B8 (pt) 2021-05-25
JP2015232012A (ja) 2015-12-24
MX2010011929A (es) 2010-11-30
DK2285411T3 (da) 2017-01-02

Similar Documents

Publication Publication Date Title
BRPI0911847A2 (pt) composições de pastilhas de nicotina
FI20085052A0 (fi) Tupakkatuote
BRPI0818163A2 (pt) produto de tabaco de fumaça
DK2634232T3 (da) Sammensætninger
BRPI0810634A2 (pt) Composições fungicidas
BRPI0914746A2 (pt) composições fungicidas
BRPI0907155A2 (pt) Composições pesticidas
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
DK2381805T3 (da) Simuleret cigaretindretning
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0912634A2 (pt) Composições pesticidas
BRPI0920278A2 (pt) artigo de fumo
IT1392101B1 (it) Composizione comprendente isoflavoni
FR2937223B1 (fr) Coupe-cigare
DK2285413T3 (da) Farmaceutisk sammensætning
DK3300729T3 (da) Terapeutiske sammensætninger indeholdende macitentan
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0919048A2 (pt) Composições pesticidas
BRPI0820198A2 (pt) composições farmacêuticas
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0916320A2 (pt) composições agrícolas
BRPI0908923A2 (pt) composições pesticidas
BRPI0912171A2 (pt) composição farmacêutica
BRPI0917935A2 (pt) Composições pesticidas
BRPI0919803A2 (pt) composições agrícolas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF